Ruda R, Franchino F, Soffietti R. Treatment of brain metastasis: current status and future directions. Curr Opin Oncol. 2016;28:502–10.

Article  CAS  PubMed  Google Scholar 

Suh JH, Kotecha R, Chao ST, Ahluwalia MS, Sahgal A, Chang EL. Current approaches to the management of brain metastases. Nat Rev Clin Oncol. 2020;17:279–99.

Article  PubMed  Google Scholar 

Sperduto PW, Mesko S, Li J, Cagney D, Aizer A, Lin NU, et al. Survival in patients with brain metastases: summary report on the updated diagnosis-specific graded prognostic assessment and definition of the eligibility quotient. J Clin Oncol. 2020;38(32):3773.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ryken TC, Kuo JS, Prabhu RS, Sherman JH, Kalkanis SN, Olson JJ. Congress of neurological surgeons systematic review and evidence-based guidelines on the role of steroids in the treatment of adults with metastatic brain tumors. Clin Neurosurg. 2019;84:E189–91.

Article  Google Scholar 

Vogelbaum MA, Brown PD, Messersmith H, Brastianos PK, Burri S, Cahill D, et al. Treatment for brain metastases: ASCO-SNO-ASTRO guideline. J Clin Oncol. 2022;40:492–516.

Article  CAS  PubMed  Google Scholar 

Horsman MR, Overgaard J. The impact of hypoxia and its modification of the outcome of radiotherapy significance of hypoxia. J Radiat Res. 2016;57:90–8.

Article  Google Scholar 

Bouleftour W, Rowinski E, Louati S, Sotton S, Wozny A-S, Moreno-Acosta P, et al. A review of the role of hypoxia in radioresistance in cancer therapy. Med Sci Monit. 2021;27:e934116–21.

Article  PubMed  Google Scholar 

Wigerup C, Påhlman S, Bexell D. Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer. Pharmacol Ther. 2016;164:152–69.

Article  CAS  PubMed  Google Scholar 

Berghoff AS, Ilhan-Mutlu A, Wöhrer A, Hackl M, Widhalm G, Hainfellner JA, et al. Prognostic significance of Ki67 proliferation index, HIF1 alpha index and microvascular density in patients with non-small cell lung cancer brain metastases. Strahlenther Onkol. 2014;190:676–85.

Article  CAS  PubMed  Google Scholar 

Berghoff AS, Ilhan-Mutlu A, Dinhof C, Magerle M, Hackl M, Widhalm G, et al. Differential role of angiogenesis and tumour cell proliferation in brain metastases according to primary tumour type: analysis of 639 cases. Neuropathol Appl Neurobiol. 2015;41:e41-55.

Article  CAS  PubMed  Google Scholar 

Ebright RY, Zachariah MA, Micalizzi DS, Wittner BS, Niederhoffer KL, Nieman LT, et al. HIF1A signaling selectively supports proliferation of breast cancer in the brain. Nat Commun. 2020;11:1–13.

Article  Google Scholar 

Kaluz S, Kaluzová M, Liao SY, Lerman M, Stanbridge EJ. Transcriptional control of the tumor- and hypoxia-marker carbonic anhydrase 9: A one transcription factor (HIF-1) show? Biochim Biophys Acta Rev Cancer. 2009;1795:162–72.

Article  CAS  Google Scholar 

Corroyer-Dulmont A, Valable S, Fantin J, Chatre L, Toutain J, Teulier S, et al. Multimodal evaluation of hypoxia in brain metastases of lung cancer and interest of hypoxia image-guided radiotherapy. Sci Rep. 2021;11:11239.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Corroyer-Dulmont A, Chakhoyan A, Collet S, Durand L, MacKenzie ET, Petit E, et al. Imaging modalities to assess oxygen status in glioblastoma. Front Med (Lausanne). 2015;2:57.

PubMed  Google Scholar 

Huang Y, Fan J, Li Y, Fu S, Chen Y, Wu J. Imaging of tumor hypoxia with radionuclide-labeled tracers for PET. Front Oncol. 2021;11:1–17.

Google Scholar 

Colombié M, Gouard S, Frindel M, Vidal A, Chérel M, Kraeber-Bodéré F, et al. Focus on the controversial aspects of 64 Cu-ATSM in tumoral hypoxia mapping by PET imaging. Front Med (Lausanne). 2015;2:58.

PubMed  Google Scholar 

Pasquali M, Martini P, Shahi A, Jalilian AR, Osso JA, Boschi A. Copper-64 based radiopharmaceuticals for brain tumors and hypoxia imaging. Q J Nucl Med Mol Imaging Off Publ Ital Assoc Nucl Med (AIMN) [and] Int Assoc Radiopharmacol (IAR), [and] Sect Soc of…. 2020;64:371–81.

Google Scholar 

Ikawa M, Okazawa H, Nakamoto Y, Yoneda M. PET imaging for oxidative stress in neurodegenerative disorders associated with mitochondrial dysfunction. Antioxidants. 2020;9:861.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fujibayashi Y, Taniuchi H, Yonekura Y, Ohtani H, Konishi J, Yokoyama A. Copper-62-ATSM: a new hypoxia imaging agent with high membrane permeability and low redox potential. J Nucl Med. 1997;38(7):1155.

CAS  PubMed  Google Scholar 

Liu T, Karlsen M, Karlberg AM, Redalen KR. Hypoxia imaging and theranostic potential of [64Cu][Cu(ATSM)] and ionic Cu(II) salts: a review of current evidence and discussion of the retention mechanisms. EJNMMI Res. 2020;10:33.

Article  PubMed  PubMed Central  Google Scholar 

Yoshii Y, Yoneda M, Ikawa M, Furukawa T, Kiyono Y, Mori T, et al. Radiolabeled Cu-ATSM as a novel indicator of overreduced intracellular state due to mitochondrial dysfunction: studies with mitochondrial DNA-less ρ0 cells and cybrids carrying MELAS mitochondrial DNA mutation. Nucl Med Biol. 2012;39:177–85.

Article  CAS  PubMed  Google Scholar 

Floberg JM, Wang L, Bandara N, Rashmi R, Mpoy C, Garbow JR, et al. Alteration of cellular reduction potential will change 64 Cu-ATSM signal with or without hypoxia. J Nucl Med. 2020;61:427–32.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dence CS, Ponde DE, Welch MJ, Lewis JS. Autoradiographic and small-animal PET comparisons between 18F-FMISO, 18F-FDG, 18F-FLT and the hypoxic selective 64Cu-ATSM in a rodent model of cancer. Nucl Med Biol. 2008;35:713–20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gangemi V, Mignogna C, Guzzi G, Lavano A, Bongarzone S, Cascini GL, et al. Impact of [64 Cu][Cu(ATSM)] PET/CT in the evaluation of hypoxia in a patient with Glioblastoma: a case report. BMC Cancer. 2019;19(1):1–4.

Article  Google Scholar 

Carlin S, Zhang H, Reese M, Ramos NN, Chen Q, Ricketts S-A. A comparison of the imaging characteristics and microregional distribution of 4 hypoxia PET tracers. J Nucl Med. 2014;55:515–21.

Article  CAS  PubMed  Google Scholar 

Pérès EA, Toutain J, Paty LP, Divoux D, Ibazizène M, Guillouet S, et al. 64Cu-ATSM/64Cu-Cl2 and their relationship to hypoxia in glioblastoma: a preclinical study. EJNMMI Res. 2019;9(1):1–5.

Article  Google Scholar 

Koh MY, Lemos R, Liu X, Powis G, Powis G. The hypoxia-associated factor switches cells from HIF-1α- to HIF-2α-dependent signaling promoting stem cell characteristics, aggressive tumor growth and invasion. Cancer Res. 2011;71:4015–27.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bordji K, Grandval A, Cuhna-Alves L, Lechapt-Zalcman E, Bernaudin M. Hypoxia-inducible factor-2α (HIF-2α), but not HIF-1α, is essential for hypoxic induction of class III β-tubulin expression in human glioblastoma cells. FEBS J. 2014;281(23):5220.

Article  CAS  PubMed  Google Scholar 

Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat methods. 2012;9(7):671.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fischer R, Kessler BM. Gel-aided sample preparation (GASP)–a simplified method for gel-assisted proteomic sample generation from protein extracts and intact cells. Proteomics. 2015;15:1224–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Demichev V, Messner CB, Vernardis SI, Lilley KS, Ralser M. DIA-NN: Neural networks and interference correction enable deep proteome coverage in high throughput. Nat Methods. 2020;17:41.

Article  CAS  PubMed  Google Scholar 

Koh MY, Powis G. Passing the baton: the HIF switch. Trends Biochem Sci. 2012;37:364–72.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gonzalez LL, Garrie K, Turner MD. Role of S100 proteins in health and disease. Biochimica et Biophysica Acta Mol Cell Res. 2020;1867:118677.

Article  CAS  Google Scholar 

Hong S-S, Lee H, Kim K-W. HIF-1alpha: a valid therapeutic target for tumor therapy. Cancer Res Treat. 2004;36:343.

Article  PubMed  PubMed Central  Google Scholar 

Oh MK, Park HJ, Kim NH, Park SJ, Park IY, Kim IS. Hypoxia-inducible factor-1α enhances haptoglobin gene expression by improving binding of STAT3 to the promoter. J Biol Chem. 2011;286:8857.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Feng Z, Fan Y, Xie J, Liu S, Duan C, Wang Q, et al. HIF-1α promotes the expression of syndecan-1 and inhibits the NLRP3 inflammasome pathway in vascular endothelial cells under hemorrhagic shock. Biochem Biophys Res Commun. 2022;637:83–92.

Article  CAS  PubMed  Google Scholar 

Krishnamachary B, Berg-Dixon S, Kelly B, Agani F, Feldser D, Ferreira G, et al. Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Res. 2003;63:1138–43.

CAS  PubMed  Google Scholar 

Qian ZM, Mei WuX, Fan M, Yang L, Du F, Yung WH, et al. Divalent metal transporter 1 is a hypoxia-inducible gene. J Cell Physiol. 2011;226:1596–603.

Article